[1] Zhang ZJ, Zhou H, Cao HE, Ji JK, Zhang RQ, Li WX, et al. Human-to-human transmission of Chlamydia psittaci in China, 2020: an epidemiological and aetiological investigation. Lancet Microbe 2022;3(7):e512 − 20. https://doi.org/10.1016/s2666-5247(22)00064-7.
[2] Hou L, Jia J, Qin XC, Fang M, Liang SN, Deng JP, et al. Prevalence and genotypes of Chlamydia psittaci in birds and related workers in three cities of China. PLoS One 2024;19(8):e0308532. https://doi.org/10.1371/journal.pone.0308532.
[3] Huang WF, Wang FG, Cai QQ, Xu HL, Hong DW, Wu H, et al. Epidemiological and clinical characteristics of psittacosis among cases with complicated or atypical pulmonary infection using metagenomic next-generation sequencing: a multi-center observational study in China. Ann Clin Microbiol Antimicrob 2023;22(1):80. https://doi.org/10.1186/s12941-023-00631-w.
[4] Sun Z, Xu K, Huo LL, Zhang XL, Wang Y, Gong YH, et al. Epidemiological features and risk factors of human psittacosis in Hangzhou City, Eastern China. Front Public Health 2025;13:1512841. https://doi.org/10.3389/fpubh.2025.1512841.
[5] Shaw KA, Szablewski CM, Kellner S, Kornegay L, Bair P, Brennan S, et al. Psittacosis outbreak among workers at chicken slaughter plants, Virginia and Georgia, USA, 2018. Emerg Infect Dis 2019;25(11):2143 − 5. https://doi.org/10.3201/eid2511.190703.
[6] Huang MZ, Wang YF, Lu Y, Qu WX, Zou QD, Zhang D, et al. Clinical characteristics and predicting disease severity in Chlamydia psittaci infection based on metagenomic next-generation sequencing. Infect Drug Resist 2025;18:1171 − 81. https://doi.org/10.2147/idr.S509879.
[7] Liu KX, Wu LL, Chen GP, Zeng DH, Zhong QW, Luo L, et al. Clinical characteristics of Chlamydia psittaci infection diagnosed by metagenomic next-generation sequencing: a retrospective multi-center study in Fujian, China. Infect Drug Resist 2024;17:697 − 708. https://doi.org/10.2147/idr.S443953.